Senior insider sale
XERIS BIOPHARMA HOLDINGS, INC. — senior position signals high conviction
$105.2K
15K shares
What this filing means
BORMANN-KENNEDY BARBARA-JEAN ANNE plans to sell 15K shares of XERIS BIOPHARMA HOLDINGS, INC. valued at approximately $105.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/12/2025ACC: 0001950047-25-010215
Director
Since Oct 2021
15K
Shares to sell
$105.2K
Approx. market value
15K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
6/7/2023
15KTotal acquired15K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/7/2023 | Restricted Stock Units N/A | 15K | — |
| Total | 15K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
15K
Market value
$105.2K
12/12/2025
Total
Units
15K
Value
$105.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/12/2025 | 15K | $105.2K | NASDAQ | Planned |
| Total | 15K | $105.2K | ||